Search results for: 'point pharmaceutical'

Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

GCC accounts only for 1.2% of the global HC revenue, but it is the region that saw the highest growth rate in the last decade. GCC has opened doors to global suppliers and moved beyond US imports, which is likely to be the game changer in the 2020s. Technology and digitization are in higher demand than ever before because of higher awareness and ...

17 Jan 2023  |  Global  |  Market Research

Regulations and Evolving Markets Drive Growth in the Quality Management Software Industry

The Enterprise-wide Capacities of Quality Management Software Drive Growth Opportunities

Infographics

×

As the QMS Systems market grows at a vertiginous pace, Frost & Sullivan provides a thorough, in-depth analysis of the dynamics shaping the industry to companies seeking entry as well as those who have already joined the fray. Quality applies to the entire product life cycle. It has implications across the entire enterprise value chain, so there...

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

Biomarker Analytics has always been one of the most in-demand branches of science relevant to the process of drug discovery and development in the Pharmaceutical Industry. Over the years several advances have been made in the area of biomarker analytics with the aim to accelerate the drug development process. The use of AI-based technology can incr...

The earth observation market is currently undergoing multiple technology and business model disruptions, largely driven by NewSpace participants in the market. Multiple small-satellite operators have entered the market and some of them have already launched their satellites. Frost & Sullivan’s research indicated that over 12,000 small-satellites wi...

05 Feb 2021  |  North America  |  Market Research

Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market

Early-stage R&D and Commercial Applications Fuel the Growth Pipeline

Infographics

×

The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...

14 Feb 2018  |  Global  |  Market Research

Global MES in Process Industry, Forecast to 2022

Cloud-based Integration of MES and ERP is Likely to Boost Adoption

Infographics

×

Key Issues Addressed

Manufacturing execution systems (MES) are the integrated software applications that provide companies the means to plan and schedule, track, direct and implement their operations. The MES market is growing due to the rapid adoption of cloud computing and data analytics in distinct industry applications around the world. The market is likely to grow...